anticipate

A CRM system can redefine customer relations in the restaurant industry

Source Node:
Time Stamp: December 22, 2023 6:11 AM - Modified On: December 22, 2023 - Published By:
Source Cluster:
Republished By Plato

When considering the importance of customer relationships in the hospitality industry, it is almost impossible not to notice how Lime Technologies can change these relationships with its CRM system. This Finnish company offers a platform that helps restaurants collect valuable customer data and use it to grow their business. Even in such a traditional and personal profession as restaurant operations, technology brings a new dimension to how customer relationships are organized and maintained. Using the CRM system to deepen the restaurant experience What are the customers' favorite dishes, when should

IQPay announces Lead Investor Steven Freidmutter Joins IQPay’s Advisory Board

Source Node:
Time Stamp: October 31, 2023 6:13 AM - Modified On: October 31, 2023 - Published By:
Source Cluster:
Republished By Plato

  Johannesburg 25 October 2023 -, IQPay an innovative force in the fintech landscape, is elated to announce that Steven Freidmutter has officially joined its advisory board. Adding to this significant appointment, Freidmutter is also stepping in as the lead investor for IQPay, marking a milestone in the company's journey. Steven Freidmutter brings to IQPay an impressive track record of experience, presence and credibility. Freidmutter's journey continues to defy conventions. His recent appointment as a partner and founding advisory board member of the Boston-based VC fund Erez Capital is a

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Travelzoo META Opens for Founding Members

Source Node:
Time Stamp: May 11, 2023 7:21 AM - Modified On: May 11, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK/PARIS/TOKYO, May 11, 2023 - (ACN Newswire) - The future of travel is here. After months of anticipation, Travelzoo META, a members-only service offering groundbreaking Metaverse travel experiences, is now accepting its first one million Founding Members. Launched by Travelzoo® (NASDAQ: TZOO), a global Internet media company, Travelzoo META will give Founding Members the opportunity to be the first to experience travel in the Metaverse. Travelzoo META's experiences are intended to allow its members to explore hard-to-reach corners of the world, like summiting Mount Everest, or travel back in time—to

TruthGPT A Revolutionary Language Model Set to Change the Game

Source Node:
Time Stamp: May 1, 2023 5:43 AM - Modified On: May 2, 2023 - Published By:
Source Cluster:
Republished By Plato

In recent years, natural language processing (NLP) has become a buzzword in the world of technology. With the increasing demand for AI-powered chatbots, virtual assistants, and content creation tools, companies are investing heavily in developing more advanced NLP systems. However, with the help of TruthGPT, the future may offer some light on the capabilities of biased AI models, despite their ability to sow social discontent, promote cultural differences, and create barriers around a more friendly and inviting globalized civic society. The Fate So Far: The Rise of Artificial Intelligence Chatbots

Digital Health and Technology Trends in the USA

Source Node:
Time Stamp: August 1, 2022 6:46 AM - Modified On: August 1, 2022 - Published By:
Source Cluster:
Republished By Plato

What role and purpose will businesses accept to impact the social contract, and how might consumer and provider empowerment might bring change to healthcare business models using technology? The Partners in Digital Health blockchain in healthcare and telehealth portfolio both reflect and set trends in the marketplace. Here are a few trends and current issues to ponder. Cost, place, and preference have prioritized the care at home care and care transitions as aging populations and a looming healthcare worker shortage impact the US health system, where virtual care presents an

Trends in Technology That Will Shape the Next Decade

Source Node:
Time Stamp: May 10, 2022 1:35 PM - Modified On: May 10, 2022 - Published By:
Source Cluster:
Republished By Plato

Technology, like money, is a driver of corporate growth, and companies are always redesigning and updating their processes to accommodate the latest advances. If you want to remain competitive, you must be infor med of what is coming next so that you can plan accordingly. In this piece, we'll take a look at some of the key issues that we anticipate will have a large impact on technology in the coming decade. From the Crypto world to IT Support, we’ll try to cover everything. Big Data and Augmented Analytics Big

Axis Technologies Group, INC. (OTCMARKETS: AXTG) Announces Intention to File Registration Statement for Public Offering of Common Stock

Source Node:
Time Stamp: March 30, 2022 2:45 PM - Modified On: March 30, 2022 - Published By:
Source Cluster:
Republished By Plato

California — March. 30, 2022 Axis Technologies Group, Inc. (OTCMARKETS: AXTG) today announced that it intends to file a registration statement with the Securities and Exchange Commission in late April 2022 for a proposed underwritten public offering of common stock. The proposed offering is expected to be predominantly from existing shareholders and be approximately $10 million. The offering is subject to market and other conditions, including the effectiveness of the registration statement to be filed under the Securities Act of 1933, as amended (the “Securities Act”). This announcement is being